Investigating the role of receptor interacting protein kinase 3 in venous thrombosis
Open Access
- 10 October 2022
- journal article
- research article
- Published by Elsevier in JVS-Vascular Science
- Vol. 3, 365-378
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01HL149404)
- National Institutes of Health (R01HL158073)
- National Institutes of Health (20CDA35350009)
- National Institutes of Health (F32HL158171)
- American Heart Association (20TPA35490307)
- American Heart Association (20CDA35350009)
This publication has 19 references indexed in Scilit:
- The post-thrombotic syndromeHematology-American Society Hematology Education Program, 2016
- The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costsThrombosis Research, 2016
- Receptor-Interacting Protein Kinase 3 Contributes to Abdominal Aortic Aneurysms via Smooth Muscle Cell Necrosis and InflammationCirculation Research, 2015
- Thrombosis: a major contributor to the global disease burdenJournal of Thrombosis and Haemostasis, 2014
- A positive feedback loop between RIP3 and JNK controls non‐alcoholic steatohepatitisEMBO Molecular Medicine, 2014
- Toll-Like Receptor 9 Signaling Is Critical for Early Experimental Deep Vein Thrombosis ResolutionArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Surveillance for Deep Vein Thrombosis and Pulmonary EmbolismAmerican Journal of Preventive Medicine, 2010
- Venous ThromboembolismAmerican Journal of Preventive Medicine, 2010
- Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced InflammationCell, 2009
- Kinase RIP3 Is Dispensable for Normal NF-κBs, Signaling by the B-Cell and T-Cell Receptors, Tumor Necrosis Factor Receptor 1, and Toll-Like Receptors 2 and 4Molecular and Cellular Biology, 2004